-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Lyell Immunopharma Announces Initiation Of Patient Dosing In First-Of-Its-Kind Phase 3 Car T-Cell Clinical Trial

Reuters·02/12/2026 13:02:24

Please log in to view news